Digital transformation in healthcare administration and hospital workflows is creating new opportunities to enhance patient experiences and reduce operational inefficiencies.
Digital transformation in healthcare administration and hospital workflows is creating new opportunities to enhance patient experiences and reduce operational inefficiencies.
READ MORE
Sports betting is increasingly recognized as contributing to a twofold public health crisis, especially impacting young men with addictive and compulsive behaviors.
A STAT reader questions whether the perceived lack of nutrition education in medical school is the true issue in prevention care.
The adoption of the TEFCA interoperability framework by the Social Security Administration is transforming the disability benefits determination process in hospitals by enabling rapid, near real-time exchange of medical records.
Oricell Therapeutics has raised $110 million in funding to develop a novel CAR-T cell therapy targeting GPC3, a protein highly expressed in liver cancer, breaking ground in a field with no FDA-approved treatments for this target.
Eli Lilly's launch of the oral obesity medication Foundayo marks a critical development in the competitive race against Novo Nordisk's established oral Wegovy, reshaping the pharmaceutical landscape for weight loss treatments.
The FDA has once again issued a complete response letter rejecting Replimune’s melanoma drug RP1, citing continued concerns over the single-arm trial used in support of its approval.
The FDA has been instructed by a Louisiana court to complete a fresh review on the safety of mifepristone while mail distribution for the pregnancy pill continues pending investigation updates.
GSK has once again pulled its regulatory application for leucovorin, a drug the FDA previously highlighted for its potential in treating autism associated with cerebral folate deficiency.
CAR-T cell therapies are showing sustained promise in inducing remissions in autoimmune diseases five years after their initial breakthrough in lupus treatment.
Democrats intensify focus on health care affordability amid rising costs, unveiling a comprehensive blueprint backed by a leading think tank.
